TribLIVE

| Home


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AGH heart specialists to join clinical trial

Daily Photo Galleries

Wednesday, March 14, 2012
 

Heart specialists at Allegheny General Hospital announced today that they will join a clinical trial investigating an implantable device designed to provide patients with coronary artery disease an early warning of an impending heart attack.

AGH is the only Pittsburgh area hospital testing the new device — the AngelMed Guardian System.

"Patient outcomes following heart attack are largely dependent upon how quickly the cardiac injury is diagnosed and therapeutic efforts are initiated to restore blood flow to the heart. Delays in that process can result in permanent damage to heart muscle," said Dr. David Lasorda, director of the hospital's division of Interventional cardiology and its principal investigator in the study.

The American Heart Association estimates that one of every five deaths in the United States is attributable to coronary heart disease. Furthermore, 50 percent of heart-attack fatalities occur within one hour of symptom onset and often before the patient even reaches the hospital.

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Stories

  1. Pitt trying to make bid for NCAA women’s field
  2. Miami’s 67-63 victory further damages Pitt’s NCAA Tourney hopes
  3. Penguins notebook: Crosby says he would play goal if needed
  4. Diabetes doesn’t slow down WPIAL wrestling duo headed for states
  5. Hempfield hockey team bolts to big lead, tops Thomas Jefferson, 7-4
  6. Agent: Polamalu undecided whether to play in 2015
  7. Ice jam wipes out McKeesport’s marina
  8. Crosby, Malkin chase scoring title amid defense-minded league
  9. 11 Ligonier Township residents rescued by boat from floodwaters
  10. Penn State Fayette tops Maine-Machias in USCAA Tournament
  11. Pirates look to put more pressure on opposition with better baserunning